TXK siRNA (Human)
Cat# MBS828059-15nmol
Size : 15nmol
Marca : MyBiosource
TXK siRNA – Tyrosine-Protein Kinase TXK (Human)
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS828059MBS828059 is an siRNA targeting TXK. Also known as TXK siRNA (Human). Reactive in Human. Host: Synthetic. siRNA to inhibit TXK expression using RNA interference More details
Product Overview
Online Datasheet in PDFProduct Name
TXK, siRNA
Full Product Name
TXK siRNA (Human)
Product Gene Name
TXK sirna
Product Synonym Names
PTK4; RLK; Tyrosine-protein kinase TXK; Protein-tyrosine kinase 4; Resting lymphocyte kinase
Host
Synthetic
Species Reactivity
Human
Form/Format
Lyophilized powder
Purity/Purification
> 97%
Specificity
TXK siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Molecular Weight
61,258 Da
OMIM
600058
Negative Control
siRNA Negative Control (Catalog# MBS8241404) is a non-targeting 21 nt siRNA recommended as a negative control for experiments using targeted siRNA transfection.
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components
We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human TXK gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
Applications Tested/Suitable for TXK sirna
RNA Interference (RNAi)
Other Notes
Small volumes of TXK sirna vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for TXK. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
tyrosine-protein kinase TXK
NCBI Official Synonym Full Names
TXK tyrosine kinase
NCBI Official Symbol
TXK
NCBI Official Synonym Symbols
RLK; TKL; BTKL; PTK4; PSCTK5
UniProt Protein Name
Tyrosine-protein kinase TXK
UniProt Synonym Protein Names
Protein-tyrosine kinase 4; Resting lymphocyte kinase
Protein Family
Tyrosine-protein kinase
UniProt Gene Name
TXK
UniProt Synonym Gene Names
PTK4; RLK
UniProt Entry Name
TXK_HUMAN
NCBI Protein Information
tyrosine-protein kinase TXK
UniProt Comments for TXK
TXK: Non-receptor tyrosine kinase that plays a redundant role with ITK in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T- cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of TXK to the cell membrane, where it is phosphorylated at Tyr-420. Phosphorylation leads to TXK full activation. Contributes also to signaling from many receptors and participates in multiple downstream pathways, including regulation of the actin cytoskekleton. Like ITK, can phosphorylate PLCG1, leading to its localization in lipid rafts and activation, followed by subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. With PARP1 and EEF1A1, TXK forms a complex that acts as a T-helper 1 (Th1) cell- specific transcription factor and binds the promoter of IFNG to directly regulate its transcription, and is thus involved importantly in Th1 cytokine production. Phosphorylates both PARP1 and EEF1A1. Phosphorylates also key sites in LCP2 leading to the up-regulation of Th1 preferred cytokine IL-2. Phosphorylates 'Tyr- 201' of CTLA4 which leads to the association of PI-3 kinase with the CTLA4 receptor. Belongs to the protein kinase superfamily. Tyr protein kinase family. TEC subfamily.
Protein type: EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); Kinase, protein; Protein kinase, TK; TK group; Tec family
Chromosomal Location of Human Ortholog: 4p12
Cellular Component: extrinsic to internal side of plasma membrane; cytoplasm; nucleus
Molecular Function: protein binding; non-membrane spanning protein tyrosine kinase activity; ATP binding; receptor binding
Biological Process: adaptive immune response; transcription, DNA-dependent; protein amino acid autophosphorylation; cytokine production; T cell receptor signaling pathway; protein amino acid phosphorylation; regulation of cell proliferation; regulation of transcription from RNA polymerase II promoter; positive regulation of interferon-gamma production; interleukin-4 production; B cell receptor signaling pathway; phospholipase C activation; interferon-gamma production; positive regulation of transcription from RNA polymerase II promoter; NK T cell differentiation; transmembrane receptor protein tyrosine kinase signaling pathway; T cell differentiation
Show more Protein type: EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); Kinase, protein; Protein kinase, TK; TK group; Tec family
Chromosomal Location of Human Ortholog: 4p12
Cellular Component: extrinsic to internal side of plasma membrane; cytoplasm; nucleus
Molecular Function: protein binding; non-membrane spanning protein tyrosine kinase activity; ATP binding; receptor binding
Biological Process: adaptive immune response; transcription, DNA-dependent; protein amino acid autophosphorylation; cytokine production; T cell receptor signaling pathway; protein amino acid phosphorylation; regulation of cell proliferation; regulation of transcription from RNA polymerase II promoter; positive regulation of interferon-gamma production; interleukin-4 production; B cell receptor signaling pathway; phospholipase C activation; interferon-gamma production; positive regulation of transcription from RNA polymerase II promoter; NK T cell differentiation; transmembrane receptor protein tyrosine kinase signaling pathway; T cell differentiation
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with TXK sirna
| Reference Product | PubMed Publications |
|---|---|
| SH2D2A sirna | >1 publications with TXK and SH2D2A |
Pathways associated with TXK sirna
| Products by Pathway | Pathway Diagram |
|---|---|
| FCERI Mediated Ca+2 Mobilization Pathway antibodies | FCERI Mediated Ca+2 Mobilization Pathway Diagram |
| Fc Epsilon Receptor (FCERI) Signaling Pathway antibodies | Fc Epsilon Receptor (FCERI) Signaling Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Immune System Pathway antibodies | Immune System Pathway Diagram |
| Innate Immune System Pathway antibodies | Innate Immune System Pathway Diagram |
| Leukocyte Transendothelial Migration Pathway antibodies | Leukocyte Transendothelial Migration Pathway Diagram |
| Leukocyte Transendothelial Migration Pathway antibodies | Leukocyte Transendothelial Migration Pathway Diagram |
Diseases associated with TXK sirna
| Disease Name | Pubmed Publications |
|---|---|
| Inflammation Antibodies | >2 publications with TXK and Inflammation |
| Necrosis Antibodies | >2 publications with TXK and Necrosis |
| Chromosome Aberrations Antibodies | >1 publications with TXK and Chromosome Aberrations |
| Kidney Diseases Antibodies | >1 publications with TXK and Kidney Diseases |
| Lung Diseases Antibodies | >1 publications with TXK and Lung Diseases |
Organs/Tissues associated with TXK sirna
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >38 publications with TXK and Blood |
| Thymus Antibodies | >6 publications with TXK and Thymus |
| Bone Marrow Antibodies | >3 publications with TXK and Bone Marrow |
| Spleen Antibodies | >2 publications with TXK and Spleen |
| Embryonic Tissue Antibodies | >2 publications with TXK and Embryonic Tissue |
| Lymph Node Antibodies | >1 publications with TXK and Lymph Node |
| Muscle Antibodies | >1 publications with TXK and Muscle |
| Lung Antibodies | >1 publications with TXK and Lung |
| Liver Antibodies | >1 publications with TXK and Liver |


